79 related articles for article (PubMed ID: 10806144)
1. Additive effects of phosphodiesterase-4 inhibition on effects of rSP-C surfactant.
Häfner D; Germann PG
Am J Respir Crit Care Med; 2000 May; 161(5):1495-500. PubMed ID: 10806144
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
Häfner D; Ibrahim M; Wollin L; Germann PG
Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630
[TBL] [Abstract][Full Text] [Related]
3. Effects of early treatment with rSP-C surfactant on oxygenation and histology in rats with acute lung injury.
Häfner D; Germann PG; Hauschke D; Kilian U
Pulm Pharmacol Ther; 1999; 12(3):193-201. PubMed ID: 10419839
[TBL] [Abstract][Full Text] [Related]
4. A rat model of acute respiratory distress syndrome (ARDS) Part 2, influence of lavage volume, lavage repetition, and therapeutic treatment with rSP-C surfactant.
Häfner D; Germann PG
J Pharmacol Toxicol Methods; 1999; 41(2-3):97-106. PubMed ID: 10598681
[TBL] [Abstract][Full Text] [Related]
5. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.
Häfner D; Germann PG; Hauschke D
Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone enhances the activity of rSP-C surfactant but not of exosurf in a rat model of the acute lung injury.
Häfner D; Germann PG
J Pharmacol Toxicol Methods; 1999 Sep; 42(1):39-48. PubMed ID: 10715602
[TBL] [Abstract][Full Text] [Related]
7. Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injury.
Häfner D; Germann PG; Hauschke D
Am J Respir Crit Care Med; 1998 Jul; 158(1):270-8. PubMed ID: 9655740
[TBL] [Abstract][Full Text] [Related]
8. Effects of C1 inhibitor and r-SP-C surfactant on oxygenation and histology in rats with lavage-induced acute lung injury.
Vangerow B; Häfner D; Rueckoldt H; Marx G; Ott N; Leuwer M; Frerking I; Germann PG
Intensive Care Med; 2001 Sep; 27(9):1526-31. PubMed ID: 11685347
[TBL] [Abstract][Full Text] [Related]
9. Intratracheally applied rSP-C surfactant exhibits no anaphylactic shock reactions in a guinea pig model of acute lung hypersensitivity.
Germann PG; Kemkowski J; Hauschke D; Steinhilber W; Häfner D
Exp Toxicol Pathol; 1999 Nov; 51(6):495-505. PubMed ID: 10661808
[TBL] [Abstract][Full Text] [Related]
10. Dosing and delivery of a recombinant surfactant in lung-injured adult sheep.
Lewis J; McCaig L; Häfner D; Spragg R; Veldhuizen R; Kerr C
Am J Respir Crit Care Med; 1999 Mar; 159(3):741-7. PubMed ID: 10051245
[TBL] [Abstract][Full Text] [Related]
11. Surfactant and inhaled nitric oxide in rats alleviate acute lung injury induced by intestinal ischemia and reperfusion.
Zheng S; Zhang WY; Zhu LW; Lin K; Sun B
J Pediatr Surg; 2001 Jul; 36(7):980-4. PubMed ID: 11431761
[TBL] [Abstract][Full Text] [Related]
12. Surfactant protein-C in ventilated premature lamb lung.
Ikegami M; Jobe AH
Pediatr Res; 1998 Dec; 44(6):860-4. PubMed ID: 9853918
[TBL] [Abstract][Full Text] [Related]
13. Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4.
Miotla JM; Teixeira MM; Hellewell PG
Am J Respir Cell Mol Biol; 1998 Mar; 18(3):411-20. PubMed ID: 9490659
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model.
Hamamoto M; Suga M; Nakatani T; Takahashi Y; Sato Y; Inamori S; Yagihara T; Kitamura S
Eur J Cardiothorac Surg; 2004 May; 25(5):833-8. PubMed ID: 15082290
[TBL] [Abstract][Full Text] [Related]
15. Effects of lung surfactant factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSF.
Häfner D; Germann PG; Hauschke D
Pulm Pharmacol; 1994 Oct; 7(5):319-32. PubMed ID: 7626919
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury.
Spragg RG; Smith RM; Harris K; Lewis J; Häfner D; Germann P
J Appl Physiol (1985); 2000 Feb; 88(2):674-81. PubMed ID: 10658037
[TBL] [Abstract][Full Text] [Related]
17. Lung function in premature rabbits treated with recombinant human surfactant protein-C.
Hawgood S; Ogawa A; Yukitake K; Schlueter M; Brown C; White T; Buckley D; Lesikar D; Benson B
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):484-90. PubMed ID: 8756826
[TBL] [Abstract][Full Text] [Related]
18. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome.
Zhu GF; Sun B; Niu SF; Cai YY; Lin K; Lindwall R; Robertson B
Am J Respir Crit Care Med; 1998 Aug; 158(2):437-43. PubMed ID: 9700118
[TBL] [Abstract][Full Text] [Related]
19. Recombinant surfactant protein C-based surfactant for patients with severe direct lung injury.
Spragg RG; Taut FJ; Lewis JF; Schenk P; Ruppert C; Dean N; Krell K; Karabinis A; Günther A
Am J Respir Crit Care Med; 2011 Apr; 183(8):1055-61. PubMed ID: 21148720
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
